Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood Bacterial DNA Load and Profiling Differ in Colorectal Cancer Patients Compared to Tumor-Free Controls.
Mutignani M, Penagini R, Gargari G, Guglielmetti S, Cintolo M, Airoldi A, Leone P, Carnevali P, Ciafardini C, Petrocelli G, Mascaretti F, Oreggia B, Dioscoridi L, Cavalcoli F, Primignani M, Pugliese F, Bertuccio P, Soru P, Magistro C, Ferrari G, Speciani MC, Bonato G, Bini M, Cantù P, Caprioli F, Vangeli M, Forti E, Mazza S, Tosetti G, Bonzi R, Vecchi M, La Vecchia C, Rossi M. Mutignani M, et al. Among authors: caprioli f. Cancers (Basel). 2021 Dec 18;13(24):6363. doi: 10.3390/cancers13246363. Cancers (Basel). 2021. PMID: 34944982 Free PMC article.
Plasma chromogranin a in patients with inflammatory bowel disease.
Sciola V, Massironi S, Conte D, Caprioli F, Ferrero S, Ciafardini C, Peracchi M, Bardella MT, Piodi L. Sciola V, et al. Among authors: caprioli f. Inflamm Bowel Dis. 2009 Jun;15(6):867-71. doi: 10.1002/ibd.20851. Inflamm Bowel Dis. 2009. PMID: 19090560
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
Caprioli F, Bosè F, Rossi RL, Petti L, Viganò C, Ciafardini C, Raeli L, Basilisco G, Ferrero S, Pagani M, Conte D, Altomare G, Monteleone G, Abrignani S, Reali E. Caprioli F, et al. Inflamm Bowel Dis. 2013 Mar-Apr;19(4):729-39. doi: 10.1097/MIB.0b013e318280292b. Inflamm Bowel Dis. 2013. PMID: 23448791
Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells.
Burrello C, Garavaglia F, Cribiù FM, Ercoli G, Lopez G, Troisi J, Colucci A, Guglietta S, Carloni S, Guglielmetti S, Taverniti V, Nizzoli G, Bosari S, Caprioli F, Rescigno M, Facciotti F. Burrello C, et al. Among authors: caprioli f. Nat Commun. 2018 Dec 5;9(1):5184. doi: 10.1038/s41467-018-07359-8. Nat Commun. 2018. PMID: 30518790 Free PMC article.
Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells.
Burrello C, Pellegrino G, Giuffrè MR, Lovati G, Magagna I, Bertocchi A, Cribiù FM, Boggio F, Botti F, Trombetta E, Porretti L, Di Sabatino A, Vecchi M, Rescigno M, Caprioli F, Facciotti F. Burrello C, et al. Among authors: caprioli f. Life Sci Alliance. 2019 Feb 13;2(1):e201800229. doi: 10.26508/lsa.201800229. Print 2019 Feb. Life Sci Alliance. 2019. PMID: 30760554 Free PMC article.
Separation of Low- Versus High-grade Crohn's Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis.
Arpa G, Grillo F, Giuffrida P, Nesi G, Klersy C, Mescoli C, Lenti MV, Lobascio G, Martino M, Latella G, Malvi D, Macciomei MC, Fociani P, Villanacci V, Rizzo A, Ferrero S, Sessa F, Orlandi A, Monteleone G, Biancone L, Cantoro L, Tonelli F, Ciardi A, Poggioli G, Rizzello F, Ardizzone S, Sampietro G, Solina G, Oreggia B, Papi C, D'Incà R, Vecchi M, Caprioli F, Caronna R, D'Errico A, Fiocca R, Rugge M, Corazza GR, Luinetti O, Paulli M, Solcia E, Di Sabatino A, Vanoli A. Arpa G, et al. Among authors: caprioli f. J Crohns Colitis. 2020 Mar 13;14(3):295-302. doi: 10.1093/ecco-jcc/jjz140. J Crohns Colitis. 2020. PMID: 31418007
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases.
Coletta M, Paroni M, Alvisi MF, De Luca M, Rulli E, Mazza S, Facciotti F, Lattanzi G, Strati F, Abrignani S, Fantini MC, Vecchi M, Geginat J, Caprioli F. Coletta M, et al. Among authors: caprioli f. J Crohns Colitis. 2020 Sep 16;14(9):1190-1201. doi: 10.1093/ecco-jcc/jjaa035. J Crohns Colitis. 2020. PMID: 32100016 Clinical Trial.
201 results